Bempikibart
Bempikibart (ADX-914) is a fully human anti-IL-7Rα antibody that re-regulates adaptive immune function by blocking signaling mediated by both IL-7 and thymic stromal lymphopoietin (TSLP) . Bempikibart can be used for the study of atopic dermatitis and alopecia areata[1].
Product Specifications
CAS Number
2622254-57-1
Product Name Alternative
ADX-914
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bempikibart.html
Purity
98.00
Solubility
10 mM in DMSO
Smiles
[Bempikibart]
Molecular Weight
(145.745 kDa)
References & Citations
[1]Bick F, et al. Targeting γc family cytokines with biologics: current status and future prospects. MAbs. 2025 Dec;17 (1) :2468312.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Eph receptor A2 Recombinant Rabbit monoclonal Antibody
Spectrin Alpha 1 (Erythrocyte Marker) (SPTA1/1832), CF647 conjugate, 0.1mg/mL
CD62L (L-Selectin) (LAM1-116), Biotin conjugate, 0.1mg/mL
Cytokeratin, pan (KRTL/1077 + KRTH/1076), Biotin conjugate, 0.1mg/mL
